Reduction of Bad Cholesterol in Patients with Diabetes
Although it is known that having high cholesterol levels is bad for your health, generally other complications such as a history of diabetes or cardiovascular disease increase risk of serious outcomes when combined with high cholesterol. Lipitor® (atorvastatin) is a medication that is commonly used to treat high cholesterol risk in patients with other risk factors such as diabetes. Unfortunately, Lipitor® is not effective in attaining desirable cholesterol levels for everybody.
Thus, the Northwest Clinical Research Center has the opportunity to conduct a clinical trial evaluating if a new medication used in combination with Lipitor® is more effective at attaining desirable cholesterol levels compared to Lipitor® alone. However, we need volunteers to complete the research to prove that these new types of treatments actually work.
All research volunteers will continue taking Lipitor® throughout the trial. The study medication is a new type of medication that will be taken in addition to atorvastatin. It is hypothesized to increase levels of good cholesterol (high-density lipoprotein) while reducing levels of bad cholesterol (low-density lipoprotein) more effectively than atorvastatin alone. Please give us a call to find out more at (425) 453-0404. We are also happy to contact you if you provide contact information at the top of this page.
HOW WE CAN HELP
Study participants are needed to evaluate if the new study medication works better than atorvastatin alone in reducing bad cholesterol levels in patients with existing diabetes or other cardiovascular risk. Complete the questionnaire or call our office at (425) 453-0404 to learn more details about the study and to determine if setting up an appointment is good for you.
All study participants receive the following at no cost:
• Clinical Evaluations
• Investigative Medication
• Medical Care